
Individual rapid antigen tests are selling for $100 each with substantially more complaints made about pharmacists than any other kind of retailer, reported The Daily Mail.
The Australian Competition and Consumer Commission has compiled a list of complaints about price gouging for home testing kits.
From Christmas Day to January 7, maximum prices surged from just $14 to $100. This was well above the wholesale costs of $3.95 to $11.45 for one test.
When it came to reported rip offs, pharmacists had the most complaints at 879 during the two-and-a-half week period covering December 25 to January 12.
This was followed by 283 for supermarkets, tobacconists and convenience stores and 272 for petrol stations.
In some cases, retailers are even refusing to give customers a receipt to hide their price gouging.
ACCC chair Rod Sims said retailers selling RATs at a huge mark-up needed to explain themselves.
‘We are asking those businesses to urgently explain the prices they are charging,’ he said.
‘In the middle of a significant outbreak of Covid-19 in a pandemic, the excessive pricing of rapid antigen tests required to diagnose the illness and protect other members of the public, is of significant concern to the ACCC.’
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Ditch WhatsApp for Paris-Made Chat App, Urges French PM to Ministers
Nov 29, 2023 by
CPI
Warren & Others Accuse Anesthesiology Giant of Anticompetitive Practices
Nov 29, 2023 by
CPI
Blackstone to Acquire Rover Group in $2.3 Billion Deal
Nov 29, 2023 by
CPI
Canada & Google Reach Deal to Preserve News in Search Results Amidst Online News Act
Nov 29, 2023 by
CPI
Adobe Gears Up to Defend Figma Deal in December 8 EU Hearing
Nov 29, 2023 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Consent Decrees
Nov 15, 2023 by
CPI
Consent Decrees Under the Biden Administration
Nov 15, 2023 by
CPI
The FTC´s Prior Approval Mischief
Nov 15, 2023 by
CPI
Fix-It-First: A Seismic Shift in U.S. Antitrust Agency Approaches to Merger Remedies
Nov 15, 2023 by
CPI
“Shadow” Settlements and the Tunney Act
Nov 15, 2023 by
CPI